Neuroscience
Booster genes may give a lift to the muscles of muscular dystrophy patients
Published in Gene Therapy Weekly, December 4th, 2003
According to a study from the United States, "more than 30 different forms of muscular dystrophy (MD) have been molecularly characterized and can be diagnosed, but progress toward treatment has been slow. Gene replacement therapy has met with great difficulty because of the large size of the defective genes and because of difficulties in delivering a gene to all muscle groups. Cell replacement therapy has also been difficult to realize."
"Will it even be possible to design specific therapy protocols for all MDs' Or is a more realistic goal to treat some of the secondary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2003-12-04)
More Articles from Gene Therapy Weekly
- Cancer Metastasis
Gene therapy containing p53 combines with CDDP to arrest liver tumor growth - Gynecology
PTEN overexpression squashes the migration of ovarian cancer cells - Cancer Therapy
Real-time imaging depicts how TRAIL can treat tumors - Cardiology
Electroporation improves DNAzyme delivery to vascular tissue - Gene Transfer
A novel amplicon system identifies obstacles to new therapies - Genetic Engineering
ONYX-015 augments radiotherapy directed against thyroid cancer cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
